Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'sd 06'

Search results for: 'sd 06'

Items 11-19 of 19

Page
per page
  1. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  2. Calpain Inhibitor II, ALLM
    A2603 Calpain Inhibitor II, ALLM
     2 Citation
    Summary: Calpain inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  3. Dasatinib (BMS-354825)
    A3017 Dasatinib (BMS-354825)
     4 Citation
    Summary: Src and BCR-Abl inhibitor
      ≥24.4 mg/mL
  4. C108297
    BA6000 C108297
    Summary: C108297 is a selective glucocorticoid receptor modulator (GR binding 0.7 nM; GR reporter gene function 0.6 nM).
  5. SB 203580 hydrochloride
    B1285 SB 203580 hydrochloride
    Target: p38
    Summary: Specific p38-MAPKs inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  6. ETP-46464
    A8626 ETP-46464
    Target: PI3K|mTOR|DNA-PK|ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥16.13 mg/mL
  7. ASP5878
    BA8938 ASP5878
    Summary: ASP5878 is an orally active, inhibitor of FGFR1, 2, 3, and 4 kinases with values of 0.47 nM, 0.6 nM, 0.74 nM, and 3.5 nM, respectively.
  8. GSK1059615
    B2176 GSK1059615
    Target: PI3K|mTOR
    Summary: PI3K and mTOR inhibitor,potent and reversible
      insoluble in EtOH; insoluble in H2O; ≥8.33 mg/mL
  9. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL

Items 11-19 of 19

Page
per page